Virtual Reality (VR) Self-Hypnosis Software

Part of paid clinical trials in New York, New York.

Sponsor
Icahn School of Medicine at Mount Sinai
Study ID
NCT06398847
Status
Recruiting
Apply to this trial

Conditions

  • Musculoskeletal Pain
  • Neuralgia
  • Neuropathic Pain

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Virtual Reality headset — DEVICE
    Self-hypnosis software in a Virtual Reality headset. This is the development of software that provides a self-hypnosis experience that can be inserted into any virtual reality device.

Study Details

This single-site study of self-hypnosis software using an off-the-shelf virtual reality (VR) device (OculusGo™) to determine the software's safety, usability, and preliminary efficacy in pain relief for HIV-associated chronic pain patients. This is funded under the i Prism Funding through Mount Sinai Innovations.

Key Dates

Start date
Mar 26, 2026
Status verified
Mar 2026
Primary completion
Jun 30, 2026
Completion
Jun 30, 2026

Study Design

Enrollment
25 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DEVICE_FEASIBILITY

Arms

  • Other: HIV-associated Chronic Pain Patients
    The participants will be enrolled into an open label arm to determine feasibility and useability of the combination device.

Primary Outcome Measure

Number of times the software is used [ Time Frame: twenty one days ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Icahn School of Medicine at Mount SinaiNew YorkNew York10029
Mary Catherine George, PhD
[email protected]
646-808-6231
Shatabdi Joshi, MS
[email protected]
212-241-9951
'David Dorfman (SUB_INVESTIGATOR)

Find similar trials in New York, NY

By research site
Icahn School of Medicine at Mount Sinai· New York, NY

Related Studies